SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 3, 2012
(Exact name of registrant as specified in its charter)
(State or other Jurisdiction
|9815 S. Monroe Street, Suite 100, Sandy, UT||84070|
|(Address of Principal Executive Offices)||(Zip Code)|
Registrants telephone number, including area code: (801) 432-9000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On February 3, 2012, in connection with its annual review of the management teams compensation packages, the Companys Board of Directors approved the recommendation of the Compensation Committee with respect to an increase of the annual base salary of Carrie E. McQueen, the Companys Chief Financial Officer, Secretary and Treasurer to $288,500, effective as of January 16, 2012. The Board of Directors retains the discretion to further adjust Ms. McQueens annual base salary at any time. Ms. McQueen will also be eligible under the Companys Annual Incentive Plan to earn a target performance bonus for fiscal year 2012 of $144,250, less all applicable withholdings and deductions. Such bonus opportunity shall be based on the
Item 8.01. Other Events
On February 7, 2012, Lifevantage Corporation issued a press release announcing, among other things, that it will release financial results for the second quarter ended December 31, 2011, after the market closes on Tuesday, February 14, 2012. A copy of the press release announcing this news is attached as Exhibit 99.1 and incorporated by
Item 9.01. Financial Statements and Exhibits
|99.1||Press release issued on February 7, 2012.|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|Dated: February 7, 2012||Lifevantage Corporation|
/s/ Carrie E. McQueen
|Carrie E. McQueen|
|Chief Financial Officer, Secretary & Treasurer|
LifeVantage to Announce Fiscal Second Quarter 2012 Results on February 14, 2012
Salt Lake City, UT February 7, 2012 LifeVantage Corporation (OTCBB:LFVN), maker of Protandim ® , the Nrf2 Synergizer patented dietary supplement, announced today it will release financial results for the second quarter ended December 31, 2011, after the market closes on Tuesday, February 14, 2012. The Company will hold an investor conference call at 2:30 p.m. Mountain time (4:30 p.m. Eastern time).
Investors interested in participating in the live call can dial (877) 604-9665 from the U.S. International callers can dial (719) 325-4886. A telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, February 16, 2012, by dialing (877) 870-5176 from the U.S., or (858) 384-5517 from international locations, and entering confirmation code 2407254.
There also will be a simultaneous, live webcast available on the Investor Relations section of the Companys web site at http://investor.lifevantage.com/events.cfm. The webcast will be archived for 30 days.
To receive email alerts regarding LifeVantages upcoming investor events, stock information, SEC filings, or Company issued press releases, please visit the Companys investor relations page and sign up for Email Subscription Alerts: http://investor.lifevantage.com/alerts.cfm .
About LifeVantage Corporation
LifeVantage, (OTCBB:LFVN), maker of Protandim ® , the Nrf2 Synergizer patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 with headquarters in Salt Lake City, UT and operations in San Diego, CA. For more information, visit www.LifeVantage.com.
Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
John Mills (310) 954-1105
Senior Managing Director, ICR, LLC